22 August 2023
30 March 2023
24 June 2022
The critical role of antivirals in the management of COVID-19 and Long COVID
by Simon Tucker, Chief Virologist, COVIRIX Medical
21 June 2022
8 June 2022
US DiaCarta and Australia's COVIRIX Medical take their Partnership from a local to a global level
8 March 2022
COVIRIX reports successful test results against Delta variant further confirming previous successful tests on SARS CoV-2.
19 November 2021
Adam Shand of Australia’s radio station MMM FM interviews Richard Li of Covirix Medical on the current state of Covid and which country is the safest.
16 November 2021
Adam Shand of MMM FM interviews Richard Li on Covirix Medical and the company’s inhalable antiviral in fighting the pandemic
Would You Take A Covid Antiviral Medication? l Richard Li - Triple M Night Shift - Omny.fm
27 May 2021 The podcast Covid Reset Season 3
Adam Shand interviews management of COVIRIX Medical: Professor Kumud Dhital CEO, Richard Li Executive Director Head of Corporate Development, and Simon Tucker Chief Virologist, on the Indian Covid second wave tragedy, the importance of antiviral treatment and the delivery of the COVIRIX antiviral as the effective weapon to help eliminate the Covid pandemic.
(to play podcast successfully, you will need to be iTunes compatible for your device’s operating system)
16 Februray 2021 ABC Radio
ABC Radio PM program interviewed Professor David Morton of Deakin University and Aerosol Scientist of Covirix Medical on nebulizer not being cause of Covid spread.
22 Februray 2021
Coronavirus: An air of confusion lingering over role of nebulisers
Source: David Morton THE AUSTRALIAN
Man at centre of nebuliser row calls for review
Source: THE AGE
Level 1, 237 East Boundary Road
Bentleigh East, Victoria, 3165
Australia
Email: contact@covirix.com
Prof Kumud Dhital
CEO & Director
kumud@covirix.com
Richard Li
Executive Director & Head of Corporate Development
richard@covirix.com
Dr Ian Nixon
CMO & Director
ian@covirix.com